3,577 Furthermore,
withholding plasma and platelet transfusion until surgical repair is complete is not supported by clinical evidence. Optimal blood replacement therapy during
open repair has not been well deÔ¨Åned nor indications
established for administration of cryoprecipitate, plasma,
and platelets.578 A retrospective study has suggested
that administration of recombinant factor VIIa in the
setting of intractable intraoperative and postoperative
bleeding during vascular surgery